cirrhosis

A major study published in Clinical Gastroenterology and Hepatology found that coffee consumption is linked to a significantly lower risk of severe liver disease, liver cancer, and liver-related death. The research, involving 354,957 UK Biobank participants over 13 years, showed that drinking 1-2 cups daily reduced cirrhosis risk by 20% and liver-related mortality by 31%, with higher consumption (5+ cups) offering even greater protection. Benefits were observed for both caffeinated and decaffeinated coffee, though adding sugar or artificial sweeteners weakened positive effects.

A large study found that coffee consumption, including decaffeinated, may reduce risks of liver disease, cirrhosis, and liver cancer. The study tracked over 354,000 participants for more than a decade, showing higher coffee intake correlated with lower risks, though associations were not proven to be causal.

Macrophage therapy delayed death and the need for liver transplants in individuals with cirrhosis, according to a study published in Nature. The treatment involved bespoke immune cells targeting the effects of cirrhosis.